Skip to main content
. 2023 Aug 27;12(17):5588. doi: 10.3390/jcm12175588

Table 3.

The univariate and multivariate regression analysis to identify prognostic factors for increased LV mass index and elevated native T1.

Variable LV Mass Index Native T1
Univariate Analysis Multivariate Analysis Univariate Analysis Multivariate Analysis
OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
Male sex 3.67
(1.39–9.69)
0.009 2.91
(0.89–9.56)
0.078 1.07
(0.33–3.45)
0.914 - -
Age, yrs 0.95
(0.90–1.00)
0.053 - - 0.96
(0.90–1.03)
0.268 - -
Hs-Tn-I, pg/L 1.00
(0.99–1.00)
0.497 - - 1.00
(0.99–1.00)
0.697 - -
BNP, pg/L 1.00
(1.00–1.01)
0.009 1.00
(1.00–1.01)
0.309 1.00
(1.00–1.00)
0.600 - -
LVEF, % 0.91
(0.86–0.97)
0.001 0.94
(0.87–1.02)
0.110 0.945
(0.90–0.99)
0.016 1.00
(0.92–1.08)
0.931
GLS, % 0.73
(0.62–0.87)
<0.001 - - 0.86
(0.75–0.99)
0.036 0.93
(0.74–1.17)
0.546
QRS voltage 1.09
(1.03–1.15)
0.002 0.98
(0.91–1.06)
0.679 1.10
(1.03–1.18)
0.006 1.08
(0.99–1.18)
0.093
PQ duration, ms 1.01
(0.99–1.03)
0.262 - - 1.00
(0.98–1.02)
0.885 - -
QRS duration, ms 1.02
(0.99–1.05)
0.296 - - 1.03
(0.99–1.07)
0.129 - -
ECG strain 12.89
(3.90–42.55)
<0.001 7.10
(1.46–34.48)
0.015 4.40
(1.23–15.72)
0.023 1.34
(0.26–7.03)
0.726

The boldface values indicate statistical significance. CI confidence interval, OR odds ratio. Abbreviations as in Table 1 and Table 2.